Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Drug Metabolism Letters|June 3, 2015
Predicting Pediatric Drug Disposition-Present and Future Directions of Pediatric Physiologically-Based PharmacokineticsShogo John Miyagi, Janel R Long-BoyleTherapeutic Drug Monitoring|March 15, 2014
Development and validation of a liquid chromatography-tandem mass spectrometry assay to quantify plasma busulfanDeborah French, Kirk K Sujishi, Janel R Long-Boyle, et al.Transplantation and Cellular Therapy|July 7, 2024
Pharmacokinetics of Briquilimab as a Conditioning Agent for Hematopoietic Stem Cell Transplantation in Patients With Severe Combined Immunodeficiency, Myelodysplastic Syndrome, or Acute Myeloid LeukemiaDawoon Jung, Janel R Long-Boyle, Wendy W Pang, et al.Blood Advances|August 27, 2021
5-Azacytidine depletes HSCs and synergizes with an anti-CD117 antibody to augment donor engraftment in immunocompetent miceAndriyana K Bankova, Wendy W Pang, Brenda J Velasco, et al.Frontiers in Pharmacology|December 24, 2021
Population Pharmacokinetic Model Development of Tacrolimus in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell TransplantationJordan T Brooks, Ron J Keizer, Janel R Long-Boyle, et al.International Journal of Pediatric Otorhinolaryngology|February 16, 2018
Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infantsJosephine A Czechowicz, Janel R Long-Boyle, Kristina W Rosbe, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2012
Busulfan, fludarabine, and alemtuzumab as a reduced toxicity regimen for children with malignant and nonmalignant diseases improves engraftment and graft-versus-host disease without delaying immune reconstitutionJason Law, Morton J Cowan, Christopher C Dvorak, et al.Journal of the American College of Clinical Pharmacy : JACCP|May 12, 2020
A Practical First Step Using Needs Assessment and a Survey Approach to Implementing a Clinical Pharmacogenomics Consult ServiceAngela Zakinova, Janel R Long-Boyle, Deborah French, et al.Therapeutic Drug Monitoring|August 28, 2014
Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical useJanel R Long-Boyle, Rada Savic, Shirley Yan, et al.Transplantation and Cellular Therapy|December 9, 2021
Busulfan dose Recommendation in Inherited Metabolic Disorders: Population Pharmacokinetic AnalysisTakuto Takahashi, Sílvia M Illamola, Cathryn A Jennissen, et al.Pageof 3